Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Vicore Pharma submits Letter of Intent for a clinical trial application for a phase II study in patients with COVID-19, SARS CoV-2 infection

Gothenburg, March 31, 2020 – Vicore Pharma, a pharmaceutical company dedicated to developing innovative medicines for rare lung disorders, today announces the submission of a Letter of Intent to file a clinical trial application (CTA) to the UK regulatory agency (MHRA[1]) for a phase II study with its proprietary compound C21 in patients with COVID-19, SARS CoV-2 infection.Together with the Letter of Intent, Vicore Pharma has submitted the first regulatory documents for initial review in a rolling submission, as recently agreed with the MHRA. The formal application will be submitted as soon

Peab builds student housing in Björkhagen

Peab has been commissioned to build 166 energy efficient student apartments in Björkhagen, south of Stockholm. The customer is Stiftelsen Stockholms studentbostäder, SSSB and the contract is worth SEK 152 million.Peab will build 166 new student apartments in Björkhagen divided into three sections consisting of two low-rise apartment buildings and one high-rise. In order to reduce both costs and construction time the buildings’ framework will be built with a prefabricated concrete consisting of so-called flat concrete slabs and external solid walls with a ready-made brick façade. The

InDex Pharmaceuticals receives grant from Vinnova for pre-clinical development of DIMS compounds in inflammation

31 mars 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that SEK 2.0 million has been granted from Sweden's innovation agency Vinnova to develop new, more effective and safer treatments for inflammatory diseases.The grant from Vinnova within the call "Innovation projects in small and medium-sized companies" will be used for a preclinical project to evaluate selected compounds from InDex’s DIMS platform in inflammatory disease models outside the field of inflammatory bowel disease. This is a continuation of the project that InDex received a grant from Vinnova for in 2016.

Annual reports 2019 – mutual funds managed by Xact Kapitalförvaltning AB

The annual reports for the full-year 2019 have been completed for the mutual funds listed below. The reports will be available today on the Management Company’s websites at: www.xact.se and www.handelsbanken.se/sv/privat/spara/fonder/fondernas-rapporter. · XACT BEAR (ETF) · XACT BEAR 2 (ETF) · XACT BULL (ETF) · XACT BULL 2 (ETF) · XACT Norden (UCITS ETF) · XACT Nordic High Dividend Low Volatility (UCITS ETF) · XACT Obligation (UCITS ETF) · XACT OBX (UCITS ETF) · XACT OBX BEAR (UCITS ETF) · XACT OBX BULL (UCITS ETF) · XACT OMXC25 (UCITS ETF) · XACT

The Annual General Meeting of Wulff Group Plc to be held on 23.4.2020 and no dividend to be distributed

STOCK EXCHANGE RELEASE  31.3.2020 at 9.00 A.M.   The Board of Directors of Wulff Group Plc has decided to postpone the time of the Annual General Meeting. The company cancels the Annual General Meeting of 2.4.2020. The company invites the shareholders to the Annual General Meeting to be held on Thursday April 23, 2020, at 12.00 in the Wulff house at Kilonkartanontie 3, Espoo. Due to the increased uncertainty from the spreading of the corona virus, the Board of Directors suggest that no dividend is distributed from financial year 2019. Earlier the Board of Directors proposed to pay out

Sinch AB (publ): Change in number of shares and votes in Sinch AB (publ)

Stockholm, Sweden – Sinch AB (publ) – XSTO: SINCH The total number of shares and votes in Sinch AB (publ), reg. no. 556882-8908 (“Sinch”), has changed during the month of March consequent upon the directed issue of 5,000,000 new shares to certain Swedish and international institutional investors and the issue of 119,456 new shares upon exercise of warrants under the incentive programme adopted by the extraordinary general meeting held on 5 December 2016. Subsequent to the directed share issue and the exercise of warrants, the total number of shares and votes in Sinch as of March 31,

Oboya's subsidiary in Denmark files for bankruptcy and takes write-downs of SEK 54 million

Oboya Horticulture Industries AB ("Oboya" or the Company) takes write-downs and provisions and files the Danish subsidiary for bankruptcy. Concluded write-downs and provisions amounted to SEK 54 million, of which SEK 0 million has a liquidity effect. Over the past year, the Danish subsidiary has shown unsatisfactory results, accentuated by the outbreak and spread of COVID-19 (coronavirus) the last few weeks. The sharp decline in the flower industry has had a strong negative impact on Oboya's Danish operations, with the Board having to file for that part of the business to go bankrupt as of

Oboya's status update related to COVID-19

Oboya Horticulture Industries AB ("Oboya" or the Company) has since the outbreak and spread of COVID-19 (corona virus) followed the development and effects closely. The Company has taken proactive measures to reduce the risk for the Company's personnel and ensure continuity of operations.The Oboya Group is a leading overall supplier of cultivation products worldwide to the flower industry as well as for fruit and vegetables. The Company is represented in many countries, such as Sweden, Denmark, Norway, Poland, China, Kenya and Vietnam. The full effects of COVID-19 remain difficult to

Change in number of shares and votes in Sweco AB (publ)

At requests of shareholders, 34 561 class A shares have been converted to class B shares during March 2020 with the support of the conversion clause in the Articles of Association. After the conversion, as per 31 March 2020, the total number of shares in Sweco amounts to 121,083,819, of which 10,385,713 are of class A, 110,698,106 are of class B representing 21,455,523.6, votes in the company. The share capital amounts to 121,083,819 SEK. On the date and time of publication of this information, Sweco holds 3,246,397 class B shares in treasury. However, Sweco has no voting rights for

Read original

Limited participation and short agenda at Telia Company’s AGM

Due to the new coronavirus Telia Company shortens the agenda for the annual general meeting on April 2, 2020 and encourages all shareholders to authorise a proxy holder instead of attending the event in person.Telia Company encourages all shareholders who wish to be represented at Telia Company’s AGM to authorise Euroclear as a proxy holder. Shareholders are in this way given the possibility to be represented at the AGM without having to be present in person. A template proxy form is available at www.teliacompany.com. Proxy documents will be collected and handled by Euroclear in accordance

An electronic signature service, SignSpace accelerates the digitalization of society: built on Nixu’s cybersecurity expertise

Press release, March 31, 2020 at 8:05 AM EESTVastuu Group, together with its partner cybersecurity company Nixu, has developed a secure digital signature platform SignSpace in Finland. The EU eIDAS compliant service is suitable for all businesses that need to sign documents. The system combines Nixu’s expertise in Public Key Infrastructure (PKI) solutions and secure software development practices in a unique way. Electronic signatures securely - online and on mobile Many of us know the feeling when seeing a huge stack of papers that need to be signed and filed away before the end of

The Sciety syndicate invests MSEK 9.1 in a cardiovascular diagnostic company

The Sciety investor syndicate recently made an investment of MSEK 9.1 in the company Cavis Technologies, which has developed Wirecath®, a patent-pending product for the diagnosis of coronary heart diseases. The new capital will be used to establish sales on the European market.“Only in Europe, over 1.5 million people die every year from coronary artery disease. The team behind Cavis Technologies has extensive experience in developing pressure wires for the diagnosis of coronary artery disease. Cavis Technologies uses a design different from existing pressure wires, which is expected to

Affärsverken and AddSecure develop unique solution for Smart Grids

In collaboration with the electrical grid owner Affärsverken in Karlskrona Elnät AB, AddSecure has developed a solution that will optimize electrical power systems. AddSecure , a leading European provider of premium solutions for secure critical communications and data, has together with Affärsverken in Karlskrona Elnät AB, developed a new solution for smart electrical grids. The analysis and data provided, support the decision-making for operations and investments in distribution networks. The project is specially selected, and funded by the Swedish Energy

Read original

BioGaia update concerning COVID-19 pandemic

BioGaia is closely monitoring the development of the COVID-19 pandemic in terms of potential impact on the business. BioGaia has taken a number of precautions and to date impact on operations has been limited.To ensure consistent supply of products BioGaia is overseeing the situation closely and prepares for adapting and taking appropriate actions with short notice. At BioGaia Production, BioGaia’s own production plant in Sweden, manufacturing is running without disruptions. For both staff safety and to guarantee supply, hygiene and cleaning routines have been further extended and the

Midsummer sells first production line under the Rusnano framework agreement

Swedish solar energy technology leader Midsummer  receives new order for a production line from Russian Nanotechnology and Nanomaterials Center of the Republic of Mordovia. The order is the first under the framework agreement Midsummer signed with Rusnano Group in September 2019. The normal order value for this type of production line stretches from 3.5 MUSD to 5 MUSD. The current order value is within this range.[Midsummer DUO the world leading turnkey system for manufacturing of flexible solar cells]  ” We are very pleased to finally be a part of the Russian

Annual General Meeting of Ratos AB - Proposed dividend is withdrawn

To better understand the consequences of the corona pandemic, Ratos's Board of Directors proposes that the Annual General Meeting, which takes place on April 1, does not decide to resolve on a dividend. Instead, the Board intends to call the shareholders to an Extraordinary General Meeting later in the year to resolve on a dividend, if the market has stabilized at this time and the company's visibility in earnings has normalized. The Board has also decided to adjust the proposal to the Annual General Meeting on long-term incentive program 2020/2025 in accordance with below.The Board's

Readly launches new branding campaign about spending quality time on your mobile

Got time? Make it count. That is the message coming from digital magazine subscription service Readly . The new branding campaign highlights that the increasing amount of time spent on scrolling social media or watching viral videos could be used for more rewarding activities such as reading quality content from the 800 publishers on the Readly platform. Readly is launching the new branding campaign in several markets across Europe. With around 5,000 national and international titles in over 16 languages, Readly is encouraging people to use their spare time on

Arjo postpones Annual General Meeting and Capital Markets Day

Arjo’s Board of Directors has today decided to postpone the Annual General Meeting (AGM). The decision is made as a result of the Swedish Government’s decision to ban public gatherings and events with more than 50 people as of Sunday, 29 March to reduce the spread of COVID-19. The decision is to be followed for other types of gatherings as well. The AGM was planned for April 27, 2020 in Malmö. Arjo now intends to hold the AGM on June 29 at 11.00 in Malmö instead. An invitation to the upcoming AGM will be issued no later than four weeks prior to the event. The Capital Markets Day,

The Board of Directors of AAK AB (publ.) proposes to postpone the decision on the dividend for 2019

The ongoing corona pandemic is profoundly impacting people’s health, societies, and business operations across the world. As a supplier of ingredients to the crucial food supply chain, AAK has a very important role to play right now. All of the company’s production plants around the world have strong contingency plans in place to secure operations and inbound/outbound logistics so that food manufacturers can maintain their production of food products. To date, AAK has not experienced any material business disruptions. Food supply will remain essential and a top priority going forward.

Bactiguard’s Annual Report 2019

The annual report for Bactiguard Holding AB (publ) 2019 is now available at www.bactiguard.comThe annual report in Swedish is now available as a downloadable PDF document. An English version will be available shortly. A printed version of the report will be available from April 28 and can be ordered by email to: info@bactiguard.se.This information is information that Bactiguard Holding AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 19.45 CET on March 30, 2020.For further information, please contact:Cecilia

Getinge postpones the Annual General Meeting due to COVID-19

Getinge’s Board of Directors has decided to postpone the Annual General Meeting as a precautionary action to reduce the spread of COVID-19. Getinge intends to hold the Annual General Meeting on June 26, 2020. A new notice to the Annual General Meeting will be published no later than four weeks before the new date for the meeting.Based on the dissemination of COVID-19, the current notification situation and the Swedish government’s decision to ban public gatherings and events with more than 50 persons, Getinge’s Board of Directors has decided to postpone the Annual General Meeting (AGM) to a

Humana AB has resolved to repurchase own shares through repurchase program

Under the authorisation from the Annual General Meeting 2019, the Board of Directors of Humana AB has decided to repurchase own shares on Nasdaq Stockholm for the purpose of enabling the transfer of own shares to participants in a share-based incentive programme to employees that has been running since 2017.Acquisition of own shares must be made on Nasdaq Stockholm in accordance with Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation) and in accordance with Commission delegated Regulation (EU) 2016/1052 of 8

There are no items matching the current filter
There are no more items matching the current filter
Back to top